Ovid Therapeutics

-$0.07 (-3.57%) Today
$0.00 (0.00%) As of 8:14 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OVID and other ETFs, options, and stocks.

About OVID

Ovid Therapeutics, Inc. is a biopharmaceutical company, engaged in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.

CEO
Jeremy Max Levin
Employees
57
Headquarters
New York, New York
Founded
2014

OVID Key Statistics

Market cap
139.88M
Price-Earnings ratio
—
Dividend yield
—
Average volume
113.34K
High today
$1.95
Low today
$1.85
Open price
$1.93
Volume
595.23K
52 Week high
$4.80
52 Week low
$1.85

OVID Earnings

-$0.38
$0.59
$1.56
$2.53
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.21 per share
Actual
-$0.23 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure